Conisus provides specialized medical communication services to the oncology pharmaceutical and biotechnology industry. The company creates innovative promotional marketing and education solutions for a diverse group of biopharmaceutical companies to assist in the promotion and education of oncology drugs and therapies.

Recapitalized into Webster Capital II-A LP on November 9, 2017.